This invention provides vaccines consisting of two Herpes Simplex Virus (HSV) proteins, a gC protein and a gE protein, and an adjuvant; and methods of vaccinating a subject against HSV and treating, impeding, inhibiting, reducing the incidence of, or suppressing an HSV infection or a symptom or manifestation thereof, comprising administration of a vaccine of the present invention.